Median Technologies, The Imaging Phenomics Company® (Paris:ALMDT) announces today that the company has signed a collaboration agreement with the New...
Takeda Pharmaceutical Company Limited announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a...
Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for...
Innovest Global Inc. announced that it has signed a Letter of Intent to acquire a Commercial Energy business, which will...
Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and...
Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, announced...
AstraZeneca today announced that the EMA has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib), a...
Merck KGaA, Darmstadt, Germany, and Pfizer Inc announced that the Phase III JAVELIN Gastric 300 trial did not meet its...
Biogen and Alkermes plc announced that they have entered into a global license and collaboration agreement to develop and commercialize...
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults. It is due to the growth of...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
